Actionable news
All posts from Actionable news
Actionable news in GILD: Gilead Sciences, Inc.,

A Look At Gilead Prior To Earnings


Gilead Reports earnings after the close today and I expect them to beat earnings.

I used a four-step process to estimate earnings for this quarter.

Based on my estimates I am predicting GAAP EPS of $2.59 and non-GAAP EPS of $3.25.

In this article, I will be providing my estimate for Gilead Sciences (NASDAQ:GILD) earnings for the upcoming quarter. After a lengthy process of data collection, I estimated that Gilead GAAP EPS will be higher then the 1 st quarter of 2016 and that non-GAAP EPS should be well above Wall. St estimates. To estimate earnings for Gilead I used a four-step process as detailed below.

A second item I noticed in my data is that Gilead is closing in on parity between revenues of HCV products...